Written by Tuesday, 11 October 2016

We have recently made a significant upgrade to the instrumentation we use in our pesticide testing. Knowing what we know about the forth-coming regulatory climate in the California cannabis market, we decided to make a large investment in two brand new SCIEX 3500 triple quadropole mass spectrometers. The greater sensitivity and expanded list of compounds afforded by this new instrumentation will aid us in preparing and empowering our clients to meet and exceed the regulations placed on their businesses by the state of California by this time next year.

IMG 2064 
There are three aspects to this upgrade.  
The first is that the sensitivity of our analysis is going…

Written by Monday, 15 August 2016

On Thursday, the United States government confirmed that Cannabis will continue to be classified as a Schedule I drug, grouping the plant in the same family as such scary substances as Heroin, Cocaine, and Meth.

DEA chief Chuck Rosenberg released a statement on Thursday explaining that a substance is classified as Schedule I when it “has no currently accepted medical use,” that’s recognized by the federal government. 


Though this announcement came as no surprise to many advocates of medical marijuana and those fighting for re-classification of the substance, the decision seemed to invoke a collective sigh of exasperation from the cannabis community. 

A silver lining may be found in the subsequent parts of the DEA’s announcement, in which the organization suggests it will take action to remove legal hurdles currently in place that are preventing groups from cultivating cannabis to be used for scientific research.

Read NPR's coverage of the announcement here.

Written by Tuesday, 26 July 2016
On Monday the California Department of Food and Agriculture's Medical Cannabis Cultivation Program (MCCP) launched an online survey. The MCCP is preparing to issue state cannabis cultivation licenses beginning in January 2018. CDFA is seeking to get a sense of how many applicants the State can expect to apply for licensure or use the Track and Trace system. “Participating in this survey is probably one of the most important things growers can do to ensure that licenses will be available for as many farms as possible. The regulatory agency needs to have a solid understanding of how many growers there are and where people are growing,” explained Hezekiah Allen, the Executive Director of the California Growers Association. “For growers in ban counties, participating in this survey may be one of the most important ways to raise awareness of the challenges being caused by regressive policies at the local level.” The survey was built with sensitivity to the growing community in mind. The Department explains that they will not be capturing any information that would indicate who is submitting information through this survey. “This survey is completely anonymous. It is short and sweet. There is no cost. There is no good…

Written by Tuesday, 24 May 2016
Recently, Baltimore Ravens tackle Eugene Monroe took to Twitter to call out NFL Commissioner Roger Goodell for refusing to modify the NFL's stance on Marijuana. Read the New York Times story here: http://www.nytimes.com/2016/05/16/sports/football/raven-calls-on-nfl-to-allow-marijuana-use-for-sports-pains.html?_r=1 Shortly after the story broke, Monroe donated $80,000 to researchers at Johns Hopkins and the University of Pennsylvania for studies to examine the impact of cannabinoid therapies on current and retired NFL players. Back in February, Senator Elizabeth Warren wrote a letter to CDC Chief Tom Friedan urging the agency to look into the impact of the legalization of medical and recreational marijuana on opioid overdose deaths. Is the mainstream fianally starting to acknowledge Cannabis as a safe alternative to dangerous prescription medications?

Written by Wednesday, 11 May 2016
As president of Envirocann, a budding cannabis certification agency, April Crittenden brings a wealth of knowledge regarding environmental stewardship and the USDA National Organic Program. April was the Senior Quality and Compliance Supervisor at California Certified Organic Farmers (CCOF) where she worked for almost a decade. In that role she crafted client communication systems, helped develop and implement the pesticide residue testing program, as well as oversaw all complaints and investigations. Prior to her years devoted to organic certification, April studied at UC Santa Cruz where she received a BA in Environmental Studies and Anthropology. She also has certificates in Permaculture, NOP & ACA trainings, and has obtained the following IOIA Inspection Certifications: Crop, Basic Post Harvest Handling/Processor, and Pesticide Residue Sampling. When April isn’t working to expand access to organically grown cannabis, she loves to snowboard, go hiking, play with her dogs and spend time gardening. Envirocann is a third party certification organization, focused on the quality assurance and quality control of cannabis production and products. Through on-site inspections and lab testing, Envirocann Certification verifies that Best Management Practices (BMP's) are used to grow and process cannabis and ensures environmental compliance to local and state regulations. Our mission is…

Written by Wednesday, 06 April 2016

SC Labs President and Co-Founder Joshua Wurzer to speak at Harvard Medical School

It’s conference season and this year Massachusetts-based Medicinal Genomics is bringing together the best and brightest in cannabis for CannMed 2016, a two-day event at Harvard Medical School. Keynote speakers include Raphael Mechoulam, the researcher who discovered THC and Orrin Devinsky, the lead investigator in GW Pharmaceuticals trials using Epidolex for Dravet Syndrome.

The conference comes at a unique time as the advent of sequencing technology has enabled personalized medicine allowing for a better understanding of the genetic regulation of the endocannabinoid system. Conference topics include the use of cannabinoid therapeutics in neurological disorders and the role of the endocannabinoid system in such disorders.

SC Laboratories President Joshua Wurzer will also be presenting a lecture entitled “Chemotypic and Quality Control Analysis of the California Medical Cannabis Market.” Medicinal Genomics also plans to present their hypothesis on the current state of the testing market and its potential impact on the diversity of the cannabis microbiome.

Where: The Joseph B. Martin Conference Center at the Harvard School of Medicine, Boston, MA
When: April 10-11, 2016
More info at: http://www.medicinalgenomics.com/cannmed2016/



Written by Friday, 19 February 2016

Skunky, fruity, floral, the bouquet of smells associated with cannabis can be highly diverse and varied from cultivar to cultivar. This diversity comes from the fragrant molecules found in cannabis called terpenes. There are over a hundred different terpenes found in cannabis, which have evolved with the cannabis plant as a defense mechanism against bacteria, fungi, insects, and other pests. They also serve as the building blocks for more complex molecules like the cannabinoids.

The Chemistry of Terpenes

Terpenes are volatile hydrocarbons that carry an aroma and are made up of small five carbon components called isoprene units. There are also similar molecules found in cannabis called terpenoids, which are modified terpenes where oxygen atoms have been incorporated or methyl groups have been added or removed. Often times the term terpenes is used more broadly to include terpenoids. Terpenes can be further categorized into three different subtypes: monoterpenes, diterpenes, and sesquiterpenes. 



Screen Shot 2016-01-07 at 11.25.56 PM

Photo taken from: http://www.ochempal.org/wp-content/images/I/isopreneunit.png

Monoterpenes are the simplest type of terpene and are made up of two isoprene…